BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2485126)

  • 1. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis.
    Wajgt A; Górny M; Szczechowski L; Grzybowski G; Ochudło S
    Acta Med Pol; 1989; 30(3-4):121-8. PubMed ID: 2485126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of high-dose prednisone medication on autoantibody specific activity and on circulating immune complex level in cerebrospinal fluid of multiple sclerosis patients.
    Wajgt A; Górny MK; Jenek R
    Acta Neurol Scand; 1983 Dec; 68(6):378-85. PubMed ID: 6666546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG; Catz I; Johnson E; Mielke B
    Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis].
    Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E
    Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].
    Ochudło S
    Wiad Lek; 1989 Dec; 41(23):1579-83. PubMed ID: 2669352
    [No Abstract]   [Full Text] [Related]  

  • 9. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG-antibodies to CNS proteins in patients with multiple sclerosis.
    Kaiser R; Obert M; Kaufmann R; Czygan M
    Eur J Med Res; 1997 Apr; 2(4):169-72. PubMed ID: 9110924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
    Lamers KJ; Uitdehaag BM; Hommes OR; Doesburg W; Wevers RA; von Geel WJ
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1334-7. PubMed ID: 2465387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
    Wajgt A; Górny M
    Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.
    Roström B; Link H; Laurenzi MA; Kam-Hansen S; Norrby E; Wahren B
    Ann Neurol; 1981 Jun; 9(6):569-74. PubMed ID: 7259119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclophosphamide changes oligoclonal immunoglobulin G spectrum in cerebrospinal fluid in slowly progressing multiple sclerosis].
    Ochudło S; Wajgt A
    Neurol Neurochir Pol; 1996; 30(1):7-16. PubMed ID: 8657352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of CSF studies to diagnosis of multiple sclerosis.
    Link H
    Ital J Neurol Sci; 1987 Jun; Suppl 6():57-69. PubMed ID: 2443465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?
    Bernard CC; Townsend E; Randell VB; Williamson HG
    Clin Exp Immunol; 1983 Apr; 52(1):98-106. PubMed ID: 6190599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on anti-myelin antibodies in patients with multiple sclerosis.
    Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G
    Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN; Layton BA; Herman PK; Kachelhofer RD; Burgard S; Bartolucci AA
    Ann Neurol; 1993 Jan; 33(1):10-7. PubMed ID: 7684211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.